Journal of Neural Transmission

, Volume 119, Issue 11, pp 1343–1350 | Cite as

Occurrence of GCH1 gene mutations in a group of Indian dystonia patients

  • Tufan Naiya
  • Amar K. Misra
  • Arindam Biswas
  • Shyamal K. Das
  • Kunal Ray
  • Jharna Ray
Basic Neurosciences, Genetics and Immunology - Original Article


The aim of this study is to examine the role of GCH1 among Indians affected with dopa responsive dystonia (DRD) and early onset Parkinson’s disease (EOPD). The patients (n = 76 including 19 DRD and 36 EOPD) and controls (n = 138) were screened for variants in GCH1 by PCR amplification of exons, splice junctions and 1 kb upstream region followed by SSCP and DNA sequencing. Four novel variants (p.Met1Val, p.Val204_205del, IVS3+68A>G, and IVS5−6T>G) were identified in 10 patients but not in the controls. In addition to two nonsynonymous changes, identified in four DRD patients in heterozygous condition, one intronic variant (IVS5−6T>G) could be linked to pathogenesis of the disease since it has the potential of altering the splice site as assessed by in silico analysis. Patients carrying different nonsynonymous variants had remarkable variation in clinical phenotype. Consistent with earlier reports, severity of clinical phenotype and the age of onset varied among family members harboring the same mutation. No mutation was detected in the EOPD patients. Three novel mutations in GCH1 gene have been found and are shown to be associated with variable clinical phenotypes mostly within the spectrum of DRD. The mutations identified represent 15.79% (3/19) of east Indian DRD patient cohort.


Dopa responsive dystonia (DRD) Dystonia EOPD GCH1 



The authors are thankful to the patients for participating in the study. The study was supported partially by grants from University Grant Commission [Grant no. F.14-38/2007(Inno./ASIST)] and Council of Scientific and Industrial Research (CSIR) (Grant no. MLP-0016 and SIP-007). TN is supported by a fellowship from CSIR, India. AB is supported by a fellowship from ICMR, India.


  1. Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE (1996) Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 5:403–406PubMedCrossRefGoogle Scholar
  2. Biswas A, Gupta A, Naiya T, Das G, Neogi R, Datta S, Mukherjee S, Das SK, Ray K, Ray J (2006) Molecular pathogenesis of Parkinson’s disease: identification of mutations in the Parkin gene in Indian patients. Parkinsonism Relat Disord 12:420–426PubMedCrossRefGoogle Scholar
  3. Brain MF, Jankovic J, Comella C, Blitzer A, Tsui J, Pullman SL (1995) Treatment of dystonia using botulinum toxin. In: Kurlan Roger (ed) Treatment of movement disorders. JB Lippincott, NewYork, pp 183–246Google Scholar
  4. Bressman SB (2003) Dystonia: phenotypes and genotypes. Rev Neurol (Paris) 159:849–856Google Scholar
  5. Claes K, Vandesompele J, Poppe B, Dahan K, Coene I, De Paepe A, Messiaen L (2002) Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene. Oncogene 21:4171–4175PubMedCrossRefGoogle Scholar
  6. Clot F, Grabli D, Cazeneuve C, Roze E, Castelnau P, Chabrol B, Landrieu P, Nguyen K, Ponsot G, Abada M, Doummar D, Damier P, Gil R, Thobois S, Ward AJ, Hutchinson M, Toutain A, Picard F, Camuzat A, Fedirko E, San C, Bouteiller D, LeGuern E, Durr A, Vidailhet M, Brice A (2009) Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with dopa-responsive dystonia. Brain 132:1753–1763PubMedCrossRefGoogle Scholar
  7. Furukawa Y, Nygaard TG, Gutlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ (1999) Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology 53:1032–1041PubMedCrossRefGoogle Scholar
  8. Furukawa Y, Guttman M, Wong H, Farrell SA, Furtado S, Kish SJ (2003) Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation. Neurology 61:269–270PubMedCrossRefGoogle Scholar
  9. Garavaglia B, Invernizzi F, Carbone ML, Viscardi V, Saracino F, Ghezzi D, Zeviani M, Zorzi G, Nardocci N (2004) GTP-cyclohydrolase I gene mutations in patients with autosomal dominant and recessive GTP-CH1 deficiency: identification and functional characterization of four novel mutations. J Inherit Metab Dis 27:455–463PubMedCrossRefGoogle Scholar
  10. Glavac D, Dean M (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 2:404–414PubMedCrossRefGoogle Scholar
  11. Grotzsch H, Schnorf H, Morris MA, Moix I, Horvath J, Prilipko O, Burkhard PR (2004) Phenotypic heterogeneity of dopa-responsive dystonia in monozygotic twins. Neurology 62:637–639PubMedCrossRefGoogle Scholar
  12. Harwood G, Hierons R, Fletcher NA, Marsden CD (1994) Lessons from a remarkable family with dopa-responsive dystonia. J Neurol Neurosurg Psychiatry 57:460–463PubMedCrossRefGoogle Scholar
  13. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S et al (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8:236–242PubMedCrossRefGoogle Scholar
  14. Jarman PR, Bandmann O, Marsden CD, Wood NW (1997) GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs. J Neurol Neurosurg Psychiatry 63:304–308PubMedCrossRefGoogle Scholar
  15. Johns MB Jr, Paulus-Thomas JE (1989) Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal Biochem 180:276–278PubMedCrossRefGoogle Scholar
  16. Loudianos G, Lovicu M, Dessi V, Tzetis M, Kanavakis E, Zancan L, Zelante L, Galvez-Galvez C, Cao A (2002) Abnormal mRNA splicing resulting from consensus sequence splicing mutations of ATP7B. Hum Mutat 20:260–266PubMedCrossRefGoogle Scholar
  17. Momma K, Funayama M, Li Y, Ichinose H, Motoyoshi K, Hattori N, Mizuno Y, Kamakura K (2009) A new mutation in the GCH1 gene presents as early-onset Parkinsonism. Parkinsonism Relat Disord 15:160–161PubMedCrossRefGoogle Scholar
  18. Naiya T, Biswas A, Neogi R, Datta S, Misra AK, Das SK, Ray K, Ray J (2006) Clinical characterization and evaluation of DYT1 gene in Indian primary dystonia patients. Acta Neurol Scand 114:210–215PubMedCrossRefGoogle Scholar
  19. Nar H, Huber R, Auerbach G, Fischer M, Hosl C, Ritz H, Bracher A, Meining W, Eberhardt S, Bacher A (1995) Active site topology and reaction mechanism of GTP cyclohydrolase I. Proc Natl Acad Sci 92:12120–12125PubMedCrossRefGoogle Scholar
  20. Nygaard TG (1993) Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 60:577–585PubMedGoogle Scholar
  21. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S (1990) Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 40:66–69PubMedCrossRefGoogle Scholar
  22. Nygaard TG, Marsden CD, Fahn S (1991) Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 41:174–181PubMedCrossRefGoogle Scholar
  23. Nygaard TG, Waran SP, Levine RA, Naini AB, Chutorian AM (1994) Dopa-responsive dystonia simulating cerebral palsy. Pediatr Neurol 11:236–240PubMedCrossRefGoogle Scholar
  24. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci 74:5463–5467PubMedCrossRefGoogle Scholar
  25. Segawa M (2000) Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 22(Suppl 1):S65–S80PubMedCrossRefGoogle Scholar
  26. Segawa M (2009) Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5). Chang Gung Med J 32:1–11PubMedGoogle Scholar
  27. Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54(Suppl 6):S32–S45PubMedCrossRefGoogle Scholar
  28. Steinberger D, Korinthenberg R, Topka H, Berghauser M, Wedde R, Muller U, German Dystonia Study Group (2000) Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of l-dopa. Neurology 55:1735–1737PubMedCrossRefGoogle Scholar
  29. Tamaru Y, Hirano M, Ito H, Kawamura J, Matsumoto S, Imai T, Ueno S (1998) Clinical similarities of hereditary progressive/dopa responsive dystonia caused by different types of mutations in the GTP cyclohydrolase I gene. J Neurol Neurosurg Psychiatry 64:469–473PubMedCrossRefGoogle Scholar
  30. Tassin J, Durr A, Bonnet AM, Gil R, Vidailhet M, Lucking CB, Goas JY, Durif F, Abada M, Echenne B, Motte J, Lagueny A, Lacomblez L, Jedynak P, Bartholome B, Agid Y, Brice A (2000) Levodopa-responsive dystonia GTP cyclohydrolase I or parkin mutations? Brain 123(Pt 6):1112–1121PubMedCrossRefGoogle Scholar
  31. Uncini A, De Angelis MV, Di Fulvio P, Ragno M, Annesi G, Filla A, Stuppia L, Gambi D (2004) Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation. Mov Disord 19:1139–1145PubMedCrossRefGoogle Scholar
  32. Watanabe T, Matsubara S, Baba Y, Tanaka H, Suzuki T, Suzuki M (2009) Successful management of pregnancy in a patient with Segawa disease: case report and literature review. J Obstet Gynaecol Res 35:562–564PubMedCrossRefGoogle Scholar
  33. Zamore PD, Patton JG, Green MR (1992) Cloning and domain structure of the mammalian splicing factor U2AF. Nature 355:609–614PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Tufan Naiya
    • 1
  • Amar K. Misra
    • 2
  • Arindam Biswas
    • 1
  • Shyamal K. Das
    • 2
  • Kunal Ray
    • 3
  • Jharna Ray
    • 1
  1. 1.S. N. Pradhan Centre for NeurosciencesUniversity of CalcuttaKolkataIndia
  2. 2.Bangur Institute of NeurosciencesKolkataIndia
  3. 3.Molecular & Human Genetics DivisionCSIR-Indian Institute of Chemical BiologyKolkataIndia

Personalised recommendations